Industry-Leading Validation Framework

Evinature’s scientific foundation is built on rigorous, peer-reviewed research conducted at the Sheba Medical Center and elite global institutions.

Sheba Medical Center is where our products are developed and validated, is consistently ranked as the 7th best hospital in the world by Newsweek.

Following the findings, the CurQD® protocol has been incorporated into the official ECCO guidelines.

Key clinical data demonstrated a significant reduction in objective biomarkers and a measurable improvement in mucosal appearance, with over 70% of participants in real-world analyses reporting a return to daily function and improved quality of life.

1. Pediatric Clinical Trial

Assessing Bowel Function and Mucosal Balance in Youth

Trial Info

Location: Leading medical centers in Israel.
Target Population: Pediatric cohort experiencing digestive challenges.
Key Findings: 70% of participants demonstrated improved bowel function within 6 weeks, with clinical data indicating the achievement of optimal mucosal balance.

View Trial

2. Efficacy of Curcumin-QingDai Combination

Evaluating the Curcumin-QingDai Combination as a Treatment Option

View Trial

Trial Info

Location: Rabin Medical Center, Israel.
Type: Case Report (observational clinical documentation).
Target Population: Adults facing chronic digestive challenges.
Key Findings: 80% significant improvement in bowel function; 75% achieved optimal mucosal balance.

3. Long-term Maintenance with CurQD®

Long-term clinical outcomes and mucosal stability.

View Trial

Trial Info

Location: Multi-center international study (including Israel).
Type: Retrospective observational study.
Key Findings: Sustained clinical response and stable mucosal balance in over 75% of participants during extended follow-up.

4. Quantifying CurQD® Efficacy and Physiological Impact

Assessing bowel function and mucosal response.

View Trial

Trial Info

Location: Multi-center study.
Type: Observational research.
Key Findings: 80% significant improvement in bowel function; 75% achieved optimal mucosal balance.

5. CurQD® Formulation and Systemic Modulation

Pharmacological synergy of Curcumin and QingDai in mucosal maintenance.

View Trial

Trial Info

Location: Multi-center investigation.
Type: Comparative observational analysis.
Key Findings: Demonstrated superior systemic modulation and enhanced barrier integrity.

6. Pediatric Application of Botanical Signaling

Safety and impact of CurQD® in pediatric populations.

View Trial

Trial Info

Location: Pediatric gastroenterology units.
Type: Observational study.
Key Findings: Positive safety profile and significant improvement in growth parameters and digestive wellness.

7. Advanced Analysis of CurQD® Mechanisms

Impact of CurQD® on mucosal barrier function and systemic balance.

View Trial

Trial Info

Location: Tertiary medical centers.
Study Type: Observational research.
Key Findings: Documented stabilization of mucosal barrier and reduction in physiological stress markers.

8. Evaluation of Botanical Synergy in Digestive Health

Efficacy of CurQD® in high-precision nutritional protocols.

View Trial

Trial Info

Location: Leading international medical centers.
Study Type: Prospective observational study.
Key Findings: High rates of improved digestive function and consistent physiological response.

9. Long-term Physiological Stability with CurQD®

Sustained impact and barrier maintenance using botanical protocols.

View Trial

Trial Info

Location: Multi-center study.
Study Type: Longitudinal observational analysis.
Key Findings: Long-term preservation of healthy mucosal status and consistent health outcomes.

10. Integrated Botanical Protocols in Practice

Real-world application of CurQD® for physiological health.

View Trial

Trial Info

Location: Multi-center collaborative study.
Study Type: Observational cohort study.
Key Findings: Consistent improvement in quality of life and physiological parameters across a diverse cohort.

Active Clinical Pipeline & Global Investigations

Our proprietary clinical studies, alongside independent research currently being conducted worldwide on our botanical compounds.

U.S. Department of Defense (DOD) Funded Study

A new clinical study, initiated by Mount Sinai Hospital, is evaluating the impact of combining the CurQD formulation with conventional health management on intestinal function metrics. The study examines the contribution of this botanical integration within a military population, aiming to assess its effect on supporting the stability and optimal function of the digestive system.

Learn More

Clinical Evaluation of DivertX in Improving Intestinal Function and Mucosal Biomarkers

A completed phase 1b trial at Tel Aviv University evaluated the performance of the DivertX botanical formulation on intestinal transit and mucosal biomarkers. The study utilized the validated Diverticular Clinical Score (DICS), demonstrating a statistically significant improvement in metrics after 8 weeks (p=0.006). These preliminary clinical signals support an ongoing multi-center, randomized, placebo-controlled trial designed to further validate the formulation’s influence on digestive function and structural stability.

Evidence-based protocols for a healthy gut